Sanjana Dayal, PhD, and Steven Lentz, MD, PhD, received a $3.36M R01 grant from the National Institute of Allergy and Infectious Diseases. The grant, titled “Cellular Effects of SARS-CoV-2 in Mediating Thrombotic Susceptibility,” will allow Dayal and Lentz to investigate whether an increase in cytokines as a result of COVID-19 can activate blood cells and […]
When Robert E. Fellows, MD, PhD, professor emeritus, started the Iowa Medical Scientist Training Program (MSTP) in 1977, no one anticipated it would become one of the oldest and strongest dual MD/PhD programs in the nation. The Iowa MSTP has produced 245 alumni who are physician-scientists with careers ranging from basic science research to clinical […]
After three years as Section Chief of Hematology in the Division of Hematology, Oncology, and Blood & Marrow Transplantation, Steven Lentz, MD, PhD, Henry Hamilton Chair in Hematology, is stepping down. For an impressive 13 years before the division’s reorganization in 2018, Dr. Lentz served as Director for the Division of Hematology and Oncology. We […]
Neointimal hyperplasia is a well-documented remodeling of the innermost vascular layer after vascular interventions and is a significant clinical outcome for many, especially people who have undergone cardiovascular procedures. Proliferation and migration of vascular smooth muscle cells (SMCs) in the innermost layer of an artery or vein results in vascular wall thickening, which leads to […]
I am pleased to announce that we have implemented a new leadership structure for the Division of Hematology, Oncology, and Blood & Marrow Transplantation (HOBMT). The missions of the division have been divided operationally into a Section of Oncology led by Mohammed Milhem, MBBS, and a Section of Hematology led by Steven Lentz, MD, PhD. […]
Steven R. Lentz, MD, PhD, Hamilton Chair in Hematology and Hematology Section Chief, presented the 2018 Sol Sherry Distinguished Lecture in Thrombosis at the American Heart Association (AHA) Scientific Sessions. In a lecture entitled “Vascular Stress Management: Oxidative Mechanisms in Thrombosis and Stroke,” Dr. Lentz presented an overview of his investigations of reduction oxidation, or […]
Dr. Steve Lentz and Dr. Firas Zahr shared a byline recently in an editorial published by the New England Journal of Medicine. Drs. Lentz and Zahr responded to a study published in NEJM, which found that by performing a simple test for the presence of a blood-clotting protein, paravalvular leaks can be readily identified and […]
Dr. Steven Lentz has recently been elected Chair of the Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB), one of the largest and most active councils of the American Heart Association. This global organization engages members working in a variety of capacities from discovery science to clinical research. The council also organizes a yearly conference […]